Novel mechanisms of atherosclerotic plaque (in)stability governed by smooth muscle cells

Novel mechanisms of atherosclerotic plaque (in)stability governed by smooth muscle cells

Translational Vascular Medicine lead by Ljubica Matic is a translational Team composed of basic researchers with expertise in molecular biology and pharmacology, and clinically active vascular surgeons. The Team applies integrative analyses combining bioinformatic and clinical data studies with murine models of vascular injury and disease, while in vitro systems based on primary cells and tissue explants are utilized for functional and mechanistic investigations.

Vascular diseases comprise conditions like atherosclerosis, aortic aneurysms and restenosis after surgical interventions, contributing to the high overall cardiovascular mortality. Pathological vessel changes are generally featured by inflammatory, apoptotic and remodeling processes involving lipids, immune and smooth muscle cells (SMCs). Given the capacity of SMCs to provide tissue integrity, we hypothesize that understanding of mechanisms that regulate their function can yield new strategies to prevent vascular complications. Therefore, we focus on novel molecular mechanisms of vascular disease particularly related to SMCs, as well as on biomarkers and therapeutic approaches in carotid atherosclerosis.

Our ultimate goal is to develop new targets for stabilizing therapies or imaging modalities aimed at early detection of vulnerable atherosclerotic plaques and patients. Our dedication to translational research in this area, as well as collaborations with numerous groups worldwide (Stanford, King’s College, Ottawa Heart Institute, Munich Technical University, etc.), have already demonstrated how a combination of clinical and experimental research has the true potential to advance the knowledge of vascular disease. 

Gåvor

Gåvor

   Om du skulle vilja stödja våra forskningsområden

   kan detta göras via Swish. 

  Vårt swish-nummer är 123-245 79 76

 

Ange namnet på den forskare vars arbete du avser att donera till.

Det går också bra att använda följande konton:

BG: 628-4418
PG: 514114-8

Ange namnet på den forskare vars arbete du avser att donera till. 

Om du befinner dig utanför Sverige, vänligen använd följande information:

Bank: SEB, Stockholm, Sweden
Kontonummer: 5201-11 370 12
Iban-nummer: SE16 5000 0000 0520 1113 7012
Bic-kod (bankens elektroniska adress): ESSESESS
Kontoinnehavare: Stiftelsen Centrum för Molekylär Medicin
L8:05, Karolinska Universitetssjukhuset
171 76 Stockholm, Sweden

GruppChefPortlet

Team leader

Ljubica Matic

E-mail

ljubica.matic@ki.se

Jobbtitel

Assistant professor

Hus

BioClinicum J8:20